Associated with poor breast cancer prognosis. Implicated in prostate cancer metastasis. In bone metastasis, Tgfb triggers metastatic cancer cells to secrete factors in the bone microenvironment that in turn favors osteolytic bone destruction. Here, TGFB1 is linked to prostate cancer.